Published in Nucleic Acids Res on January 15, 1996
Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci U S A (1998) 1.33
Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol (2000) 1.28
Modulating nuclear receptor function: may the phos be with you. J Clin Invest (1999) 1.11
The G115S mutation associated with maturity-onset diabetes of the young impairs hepatocyte nuclear factor 4alpha activities and introduces a PKA phosphorylation site in its DNA-binding domain. Biochem J (2004) 0.82
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
The steroid and thyroid hormone receptor superfamily. Science (1988) 25.68
CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res (1987) 15.65
Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature (1978) 11.49
Transcription activation by the adenovirus E1a protein. Nature (1989) 9.08
Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J (1988) 8.02
Isolation of the yeast regulatory gene GAL4 and analysis of its dosage effects on the galactose/melibiose regulon. Proc Natl Acad Sci U S A (1982) 6.22
Nuclear receptors enhance our understanding of transcription regulation. Trends Genet (1988) 5.95
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell (1992) 5.87
A myogenic cell line with altered serum requirements for differentiation. Differentiation (1977) 5.30
Isolation and preliminary characterization of the GAL4 gene, a positive regulator of transcription in yeast. Proc Natl Acad Sci U S A (1982) 4.93
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev (1992) 4.69
An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol (1990) 4.24
Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem Sci (1992) 3.63
Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J (1991) 2.75
Role of retinoids in differentiation and carcinogenesis. Cancer Res (1983) 2.74
Promoter context- and response element-dependent specificity of the transcriptional activation and modulating functions of retinoic acid receptors. Cell (1992) 2.50
Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. Mol Endocrinol (1990) 2.42
RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimerization in vivo. EMBO J (1993) 2.17
The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res (1989) 2.05
Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors. J Biol Chem (1993) 1.77
Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res (1992) 1.68
Retinoic acid receptor gamma: specific immunodetection and phosphorylation. J Cell Biol (1991) 1.44
Mouse retinoid X receptor contains a separable ligand-binding and transactivation domain in its E region. Mol Cell Biol (1995) 1.28
Phosphorylation of the retinoic acid receptor-alpha by protein kinase A. Mol Endocrinol (1995) 1.26
Developmental expression of murine retinoid X receptor (RXR) genes. Mech Dev (1994) 1.24
Phosphorylation of steroid hormone receptors. Endocr Rev (1992) 1.22
A 10-amino-acid sequence in the N-terminal A/B domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol Cell Biol (1995) 1.21
Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol (1992) 1.16
Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor. Mol Cell Biol (1994) 1.06
Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol Endocrinol (1995) 1.03
Protein phosphatases 1 and 2A regulate the transcriptional and DNA binding activities of retinoic acid receptors. J Biol Chem (1995) 0.93
The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain. Mol Endocrinol (1993) 0.92
Modification of the retinoic acid signaling pathway by the catalytic subunit of protein kinase-A. Mol Endocrinol (1993) 0.90
Identification of deoxyribonucleic acid sequences that bind retinoid-X receptor-gamma with high affinity. Endocrinology (1994) 0.83
A protein kinase C-dependent activity modulates retinoic acid-induced transcription. Mol Endocrinol (1993) 0.82
SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol (1997) 3.84
Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell (2001) 2.69
Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature (1988) 1.95
A dynamic role for HDAC7 in MEF2-mediated muscle differentiation. J Biol Chem (2001) 1.68
The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation. Genes Dev (2000) 1.59
Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains. Genomics (1988) 1.37
Two receptor interaction domains in the corepressor, N-CoR/RIP13, are required for an efficient interaction with Rev-erbA alpha and RVR: physical association is dependent on the E region of the orphan receptors. Nucleic Acids Res (1996) 1.28
Subcellular localization of the steroid receptor coactivators (SRCs) and MEF2 in muscle and rhabdomyosarcoma cells. Mol Endocrinol (2001) 1.14
Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family. Mol Endocrinol (1995) 1.13
The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD. Mol Endocrinol (1999) 1.08
Identification of a thyroid hormone response element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ (1993) 1.07
Transcriptional repression by the orphan steroid receptor RVR/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis. Nucleic Acids Res (1996) 1.04
Early responses of trans-activating factors to growth hormone in preadipocytes: differential regulation of CCAAT enhancer-binding protein-beta (C/EBP beta) and C/EBP delta. Mol Endocrinol (1995) 1.02
Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD. Nucleic Acids Res (1999) 1.02
Trans-activation and DNA-binding properties of the transcription factor, Sox-18. Nucleic Acids Res (1995) 1.00
Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains. Mol Endocrinol (2000) 1.00
Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha. Mol Endocrinol (1998) 0.97
Changes in levels of actin and tubulin mRNAs upon the lectin activation of lymphocytes. Mol Cell Biol (1984) 0.96
Prenatal expression of the growth hormone (GH) receptor/binding protein in the rat: a role for GH in embryonic and fetal development? Development (1992) 0.96
Repression of basal transcription by vitamin D receptor: evidence for interaction of unliganded vitamin D receptor with two receptor interaction domains in RIP13delta1. J Mol Endocrinol (1998) 0.95
Domains of Brn-2 that mediate homodimerization and interaction with general and melanocytic transcription factors. Eur J Biochem (2000) 0.94
Sequence and expression of Sox-18 encoding a new HMG-box transcription factor. Gene (1995) 0.94
Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13delta1. J Steroid Biochem Mol Biol (1998) 0.93
The orphan nuclear receptor, COUP-TF II, inhibits myogenesis by post-transcriptional regulation of MyoD function: COUP-TF II directly interacts with p300 and myoD. Nucleic Acids Res (1998) 0.92
SOX18 directly interacts with MEF2C in endothelial cells. Biochem Biophys Res Commun (2001) 0.91
Transcriptional modulation of mouse mu-opioid receptor distal promoter activity by Sox18. Mol Pharmacol (2001) 0.90
Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest (2001) 0.89
Cloning and functional analysis of the Sry-related HMG box gene, Sox18. Gene (2001) 0.88
Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. Nucleic Acids Res (1996) 0.88
Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target. J Mol Biol (1999) 0.87
The retinoic acid and retinoid X receptors are differentially expressed during myoblast differentiation. Endocrinology (1994) 0.83
Identification of deoxyribonucleic acid sequences that bind retinoid-X receptor-gamma with high affinity. Endocrinology (1994) 0.83
The human skeletal alpha-actin promoter is regulated by thyroid hormone: identification of a thyroid hormone response element. Cell Growth Differ (1992) 0.81
Structure, mapping, and expression of human SOX18. Mamm Genome (2000) 0.81
Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts. Cancer Res (1983) 0.79
Growth-related changes in specific mRNAs upon lectin activation of human lymphocytes. DNA (1985) 0.79
Expression and cytoplasmic localisation of deoxyuridine triphosphate pyrophosphatase encoded by a human endogenous retrovirus. Arch Virol (2000) 0.79
The effects of lectin transformation on cytoplasmic polyadenylated RNA from human lymphocytes. Mol Cell Biochem (1983) 0.78
Sox18 expression in blood vessels and feather buds during chicken embryogenesis. Gene (2001) 0.77
Differential gene expression during lectin induced transformation of human lymphocytes. Prog Clin Biol Res (1986) 0.75
Poly(A)+RNA as a possible target for deoxyadenosine induced G1/G0 lymphotoxicity. Adv Exp Med Biol (1984) 0.75